Report ID :10151775 |
Published Date : 21 Oct 2022 |
Report Format : |
Delivery Timeline :48-72 Business Hours
In 2021, the global respiratory synctial virus Diagnostics market size is estimated to be ~USD 800 million and is expected to grow at a CAGR of 10% during the forecast period 2022-2030. Rising respiratory infection rates, growing neonatal population, growing demand for laboratory diagnostics and growing demand for healthcare facilities are the major drivers of market growth. Due to rapid growth during the forecast period. As the prevalence of chronic diseases worldwide increases, respiratory infections are also expected to increase. In addition, the market demand for infectious disease screening such as RSV is expected to increase. This infection is a leading cause of infant death and can be prevented with early diagnosis and treatment. According to an article in Newborn Death and Disease Reduction, Defensive Strategic Consensus in Latin America and Caribbean, about 400,000 children die before the age of 5, 270,000 of which occur in the first half of the year. We warn health authorities about these cases because these deaths are due to preventable infections. The Pan American Health Organization (PAHO) and Latin American Perinatal Health Center are focused on educating parents on how to prevent potential infections and improve RSV diagnosis rates. In addition, the high incidence of pneumonia in children is expected to increase the demand for RSV testing. According to the World Health Organization (WHO), in 2001, about 151.8 million children were diagnosed with pneumonia in developing countries, including Latin America. It is estimated that around 1.9 million of these cases have died, and the total infant population worldwide is growing, with a similar trend expected over the next seven years. based on world population Product Information: Products on the market for airway obstruction virus detection include direct immunofluorescence (DFA), rapid antigen testing (RADT), molecular detection, chromatographic testing, diagnostic imaging, gel droplets, cytometry, and flow rates. . One method to evaluate the safety of chromatography is gravity assisted testing and oligo chromatography (OC). In 2014, molecular identification was the most common because of the higher accuracy of molecular formulas compared to other methods. It is the gold standard for RSV detection, the most accurate method for molecular detection of RSV, and the most common mechanisms are reverse transcription of polymerase chain reaction (RT-PCR) and DNA multiplexing. From 2014 to 2015, several molecular detection tests were introduced, including the Cepheid Xpert Flu/RSV XC, Simplexa Flu A/B and RSV tests, and Verizons respiratory viral nucleic acid test. Additionally, advances in genomics and proteomics research will lead to the introduction of new molecular methods for diagnosing RSV. Rapid Antigen Detection Testing (RADT) predicts profitability will increase over time with benefits such as shorter time to results, elimination of additional tests, earlier diagnosis, delivery of treatment, and improved antibiotic management. This is a test of care (POC) and can be done in an emergency room or clinic. Additionally, these tests follow patients from the start of treatment and have a positive impact on clinical decisions. End-Use Information: Based on end-use, the adjacent respiratory virus detection market is segmented into hospitals, laboratories, clinics, and home care. Hospitals have the largest share of the market and are expected to conquer the market during the forecast period. Because RSV infection is widespread in neonates, treatment in this population must be monitored 24 hours a day, resulting in increased hospitalizations for RSV infection. Regional Outlook: In 2020, the obstructive respiratory virus diagnostics market dominated North America due to the high prevalence of this infection and the increase in the number of newborns during the forecast period. Molecular detection and safety measures are common elements of chromatography. As a discipline, they produce accuracy, sensitivity and specificity, which is rapidly increasing demand. With increasing strategic partnerships between leading pharmaceutical companies and laboratory diagnostics manufacturers for creating mobile diagnostics, this industry must be lucrative and have great potential. A period of high population density and expected rapid spread of infectious diseases. The market growth is expected to be driven by strong demand for automated health tests for rapid and accurate disease diagnosis in China, India, Japan and Malaysia. government initiative In addition, the market is expected to grow due to the rise in medical expenses in developing countries such as Brazil, Mexico, India and Saudi Arabia and the number of children exceeding the government subsidy budget. The existence of untapped opportunities, continuous improvement of healthcare infrastructure, economic growth and increasing patient awareness are the factors supporting the rapid growth of these sectors. The sections included in this report: Forecast revenue growth and provide an analysis of the latest trends in each sub-sector from 2022-2030. In this study, Kenneth Research Intermittent Respiratory Virus Detection by Product, End Use, and Region Market Report: Product Overview (Sales, Million Dollar, 2022-2030 Direct Immunofluorescence (DFA) Rapid Diagnostic Antigen Test (RADT) Troubleshooting Diagnostic Chromatography Experiments Accurate Gravity (OC) Imaging Others Based on End-Use Prospects (Performance, Millions, 2022-2030) ) Hospitals, Laboratories, Clinics, Home Care.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
